Benzinga | Aug 25, 2020 12:58PM EDT

Jefferies Assumes Verona Pharma at Buy, Announces Price Target of $17

Jefferies assumes Verona Pharma (NASDAQ:VRNA) with a Buy rating and announces Price Target of $17.